White Paper
Politics ‘Trumps’ Rational Policy Rule Change On Ending Rebates To PBMs For The Medicare Program
This paper explores the reason behind this about-face, potential policy alternatives President Trump may pursue to reduce drug prices and their adverse consequences, and what shoul ...
White Paper
Proposed Rule To End Rebates To PBMs For Medicare And Medicaid Programs
This white paper looks at how rebates to PBMs relate to drug prices from two perspectives: how they are supposed to work versus what actually happens. ...
White Paper
Growing Attention Being Paid To Pharma Company Rebates And Discounts
Pharma companies need to better understand how to manage rebates and discounts, while also developing a broader view of the effect on patients and the healthcare system. ...
